$332.29
7.742.38%
Last update: Oct 30, 6:54 PM
Krystal Biotech Inc (KRYS) Stock Price, Quote, News & History
KRYSNASDAQ
Krystal Biotech reports clinical updates for KB113, showing over an 80% reduction in basal cell carcinoma lesions in Gorlin syndrome.
You can purchase shares of Krystal Biotech (NASDAQ:KRYS) through any online brokerage.
Other companies in Krystal Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Krystal Biotech has a consensus price target of $319.80.
The stock price for Krystal Biotech (NASDAQ: KRYS) is $328 last updated October 30, 2026 at 6:54 PM EDT.
There are no upcoming dividends for Krystal Biotech.
Krystal Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Krystal Biotech.
Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its...
